Marco C Pinho Selected Research

Marco C Pinho Research Topics

11	Neoplasms (Cancer) 05/2022 - 11/2013
7	Brain Neoplasms (Brain Tumor) 11/2020 - 08/2014
6	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 11/2013
6	Glioma (Gliomas) 01/2020 - 08/2014
2	Disease Progression 09/2018 - 01/2014
1	Pathologic Constriction (Stenosis) 09/2022
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Hypercapnia 01/2021
1	Craniocerebral Trauma (Head Injury) 12/2020
1	Brain Concussion (Cerebral Concussion) 12/2020
1	Breast Neoplasms (Breast Cancer) 11/2020
1	Nervous System Diseases (Neurological Disorders) 09/2017
1	Neoplasm Metastasis (Metastasis) 06/2014

5	Biomarkers (Surrogate Marker)IBA 09/2022 - 11/2013
5	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2021 - 01/2018
4	alpha-hydroxyglutarateIBA 01/2020 - 01/2017
3	cediranib (AZD2171)IBA 01/2017 - 11/2013
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2021 - 06/2015
2	Pyruvic Acid (Pyruvate)IBA 01/2021 - 12/2020
2	GadoliniumIBA 01/2020 - 09/2018
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2020 - 09/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014 - 11/2013
1	Acetazolamide (Diamox)FDA LinkGeneric 01/2021
1	Carboplatin (JM8)FDA LinkGeneric 11/2020
1	Bevacizumab (Avastin)FDA Link 11/2020
1	Glycine Dehydrogenase (Decarboxylating)IBA 01/2020
1	Amino Acids FDA Link 01/2020
1	CarbonIBA 01/2020
1	EnzymesIBA 01/2020
1	NucleotidesIBA 01/2020
1	Glycine Hydroxymethyltransferase (Serine Hydroxymethyltransferase)IBA 01/2020
1	Choline (Choline Chloride)IBA 01/2017
1	Indicators and Reagents (Reagents)IBA 01/2017
1	CreatineIBA 01/2017
1	Temozolomide (Temodar)FDA LinkGeneric 01/2017
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2017
1	Protons (Proton)IBA 06/2015
1	Citric Acid (Citrate)FDA LinkGeneric 08/2014
1	Contrast MediaIBA 07/2014
1	thiamine triphosphorate (TTP)IBA 01/2014
1	Placenta Growth FactorIBA 11/2013